BICLUSTER_ID : UPREG-192
PATHOGENS /3/ : pseudomonas aeruginosa,helicobacter pylori,ehrlichia chaffeensis
TARGETS /8/ : CCL2, TNFRSF1B, SERPINB2, SERPINE1, ICAM1, IL1R1, TLR2, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPPFKFB3, KLF6, TNFRSF1B, PMAIP1, SRC, FAS, SERPINE1, IFI44, ICAM1, PLAUR, IER3
NETPATH IL 4 PATHWAY DOWNNFKBIA, GADD45B, ICAM1, CCL2, CXCL2, TLR2
NCI DISSOLUTION OF FIBRIN CLOTSERPINB2, PLAUR
NCI AMB2 NEUTROPHILS PATHWAYSRC, ICAM1, PLAUR
NETPATH IL 5 PATHWAY UPPLSCR1, BIRC3, NFKBIE, CCL2, ICAM1, RELB, MYD88, EGR2, IER3
NETPATH IL 9 PATHWAY UPCCL2
NCI IL23PATHWAYNFKBIA, CXCL1, CCL2
NCI IL1PATHWAYIL1R1, MYD88
GERY CEBP TARGETSGADD45B, IFRD1, CXCL1, PLAUR, DUSP1
NETPATH IL 1 PATHWAY UPNFKBIA, BIRC3, CXCL1, ICAM1, NFKBIE, CXCL2
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
WEINMANN ADAPTATION TO HYPOXIA DN
VARELA ZMPSTE24 TARGETS UP
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
AMIT EGF RESPONSE 40 HELA
NETPATH IL 7 PATHWAY UPFAS, CXCL1, CXCL2
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI IL6 7PATHWAY
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
ROETH TERT TARGETS UP
BIOCARTA LAIR PATHWAY
FRIDMAN IMMORTALIZATION DN
HINATA NFKB TARGETS KERATINOCYTE UP
MARKEY RB1 ACUTE LOF UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
OSADA ASCL1 TARGETS DN
BIOCARTA LYM PATHWAY
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
HUANG FOXA2 TARGETS UP
TSAI RESPONSE TO IONIZING RADIATION
DIRMEIER LMP1 RESPONSE EARLY
CORUM RIBOSOME CYTOPLASMICRPL30, RPS15A, RPS11, RPL23A, RPL14, RPS10, RPL39, RPS21, RPS5, RPS8, RPL35A, RPL13A, RPL32, RPS23, RPS19
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
AMIT EGF RESPONSE 120 HELA
DEBOSSCHER NFKB TARGETS REPRESSED BY GLUCOCORTICOIDS
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
MCLACHLAN DENTAL CARIES UP
PODAR RESPONSE TO ADAPHOSTIN UP
NCI VIRAL MRNA TRANSLATIONRPL30, RPS15A, RPS11, RPL23A, RPL14, RPS10, RPL39, RPS21, RPS5, RPS8, RPL35A, RPL13A, RPL32, RPS23, RPS19
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
REACTOME VIRAL MRNA TRANSLATION
GAURNIER PSMD4 TARGETS
HELLER SILENCED BY METHYLATION UP
NCI EUKARYOTIC TRANSLATION TERMINATIONRPL30, RPS15A, RPS11, RPL23A, RPL14, RPS10, RPL39, RPS21, RPS5, RPS8, RPL35A, RPL13A, RPL32, RPS23, RPS19
NCI PEPTIDE CHAIN ELONGATIONRPL30, RPS15A, RPS11, RPL23A, RPL14, RPS10, RPL39, RPS21, RPS5, RPS8, RPL35A, RPL13A, RPL32, RPS23, RPS19
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
MARKEY RB1 CHRONIC LOF DN
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
WONG ENDMETRIUM CANCER UP
AMIT SERUM RESPONSE 120 MCF10A
SESTO RESPONSE TO UV C3
KEGG RIBOSOME
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
GEISS RESPONSE TO DSRNA UP
NCI IL12 2PATHWAY
TIAN TNF SIGNALING VIA NFKB
ZHU CMV ALL UP
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
NATSUME RESPONSE TO INTERFERON BETA UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
HINATA NFKB TARGETS FIBROBLAST UP
AMIT EGF RESPONSE 60 MCF10A
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
LEONARD HYPOXIA
NCI FORMATION OF A POOL OF FREE 40S SUBUNITSRPL30, RPS15A, RPS11, RPL23A, RPL14, RPS10, RPL39, RPS21, RPS5, RPS8, RPL35A, RPL13A, RPL32, RPS23, RPS19
CROONQUIST STROMAL STIMULATION UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
HALMOS CEBPA TARGETS UP
WALLACE PROSTATE CANCER RACE UP
SAGIV CD24 TARGETS DN
HORIUCHI WTAP TARGETS UP
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
BASSO CD40 SIGNALING UP
MUELLER METHYLATED IN GLIOBLASTOMA
NCI IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
MARZEC IL2 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
SOUCEK MYC TARGETS
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
MAHADEVAN RESPONSE TO MP470 UP
FERRARI RESPONSE TO FENRETINIDE UP
BILD HRAS ONCOGENIC SIGNATURE
DAUER STAT3 TARGETS UP
LIANG SILENCED BY METHYLATION 2
NETPATH IL 3 PATHWAY UP
BIOCARTA CTL PATHWAY
KEGG LEISHMANIA INFECTION
NETPATH IL 6 PATHWAY UPMAFF, GADD45B, CXCL1, CEBPD, JUNB, CEBPB, IRF1, SBNO2
CHO NR4A1 TARGETS
LEE LIVER CANCER ACOX1 UP
WANG ESOPHAGUS CANCER PROGRESSION UP
WU HBX TARGETS 1 UP
REACTOME PEPTIDE CHAIN ELONGATION
BERENJENO TRANSFORMED BY RHOA FOREVER DN
DAZARD UV RESPONSE CLUSTER G2
CHEN HOXA5 TARGETS 9HR UP
MCLACHLAN DENTAL CARIES DN
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
ZHU CMV 8 HR UP
SANA TNF SIGNALING UP
BIOCARTA INFLAM PATHWAY
SENESE HDAC1 AND HDAC2 TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS UP
ONDER CDH1 TARGETS 2 DN
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
SENESE HDAC3 TARGETS UP
KEGG CHEMOKINE SIGNALING PATHWAY
KEGG CYTOSOLIC DNA SENSING PATHWAY
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
BIOCARTA GRANULOCYTES PATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
BIOCARTA TOLL PATHWAY
REACTOME FORMATION OF A POOL OF FREE 40S SUBUNITS
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
pseudomonas aeruginosa fdr440helicobacter pylori kx2 mgepehrlichia chaffeensis libertyGeneSet Name
0.00843 0.04909 0.01786NETPATH_IL_2_PATHWAY_UP
0.00000 0.00009 0.00340NETPATH_IL_4_PATHWAY_DOWN
0.03838 0.06512 0.11045NCI_DISSOLUTION_OF_FIBRIN_CLOT
0.00315 0.08235 0.01327NCI_AMB2_NEUTROPHILS_PATHWAY
0.00726 0.00002 0.05924NETPATH_IL_5_PATHWAY_UP
0.04269 0.00202 0.00207NETPATH_IL_9_PATHWAY_UP
0.01471 0.01454 0.00440NCI_IL23PATHWAY
0.07208 0.02503 0.08937NCI_IL1PATHWAY
0.00131 0.00038 0.05794GERY_CEBP_TARGETS
0.00000 0.00000 0.04640NETPATH_IL_1_PATHWAY_UP
0.01700 0.00541 0.01105GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.01567 0.02716 0.11374WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.05018 0.00016 0.00228VARELA_ZMPSTE24_TARGETS_UP
0.00068 0.07361 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.00000 0.00000 0.02223LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.06380 0.00292 0.06455BIOCARTA_IL1R_PATHWAY
0.00000 0.00000 0.09956RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00003 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.15015 0.00053 0.15480AMIT_EGF_RESPONSE_40_HELA
0.00003 0.00019 0.00005NETPATH_IL_7_PATHWAY_UP
0.06558 0.00313 0.03802YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00005 0.00000 0.03458JEON_SMAD6_TARGETS_UP
0.01817 0.00011 0.14846MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00052 0.00010 0.01294THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.14730 0.09551 0.00014NCI_IL6_7PATHWAY
0.11741 0.09686 0.06656TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.10124 0.11818 0.00000LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.10447 0.08283 0.00140ROETH_TERT_TARGETS_UP
0.01830 0.00141 0.00723BIOCARTA_LAIR_PATHWAY
0.05960 0.14744 0.15168FRIDMAN_IMMORTALIZATION_DN
0.00000 0.00000 0.00058HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.01820 0.09595 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00034 0.00019 0.00966KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.11392 0.14030 0.00584OSADA_ASCL1_TARGETS_DN
0.01705 0.06917 0.00168BIOCARTA_LYM_PATHWAY
0.00021 0.02487 0.11368NUYTTEN_EZH2_TARGETS_UP
0.00513 0.00000 0.00023DUTTA_APOPTOSIS_VIA_NFKB
0.17959 0.01079 0.10032HUANG_FOXA2_TARGETS_UP
0.04793 0.00328 0.05204TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00002 0.00124 0.00342DIRMEIER_LMP1_RESPONSE_EARLY
0.00000 0.00000 0.01621CORUM_RIBOSOME_CYTOPLASMIC
0.03514 0.13453 0.08853KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.00009 0.00000 0.00023REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00010 0.00000 0.05362ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00194 0.00020 0.16184ONDER_CDH1_TARGETS_3_DN
0.00068 0.00007 0.00639AMIT_EGF_RESPONSE_120_HELA
0.02560 0.12727 0.16474DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS
0.05763 0.00467 0.00000NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.01078 0.00622 0.04791NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.01555 0.17266 0.07034FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00001 0.00006 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.13382 0.00000 0.00465PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00000 0.00000 0.02372NCI_VIRAL_MRNA_TRANSLATION
0.08516 0.04908 0.04493TAVOR_CEBPA_TARGETS_UP
0.00037 0.00146 0.00078FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00000 0.02961REACTOME_VIRAL_MRNA_TRANSLATION
0.00002 0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.01964 0.08092 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.00000 0.00000 0.02343NCI_EUKARYOTIC_TRANSLATION_TERMINATION
0.00000 0.00000 0.03274NCI_PEPTIDE_CHAIN_ELONGATION
0.01084 0.15948 0.09089SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.05680 0.05877 0.00116MARKEY_RB1_CHRONIC_LOF_DN
0.00710 0.18998 0.00253SMID_BREAST_CANCER_LUMINAL_B_DN
0.00027 0.00059 0.03822ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.04320 0.07293 0.13528WONG_ENDMETRIUM_CANCER_UP
0.02960 0.00109 0.00533AMIT_SERUM_RESPONSE_120_MCF10A
0.02538 0.00018 0.11456SESTO_RESPONSE_TO_UV_C3
0.00000 0.00000 0.04577KEGG_RIBOSOME
0.00218 0.00145 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.04896 0.00158 0.00011BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.00007 0.00000 0.01274GEISS_RESPONSE_TO_DSRNA_UP
0.06732 0.10946 0.00032NCI_IL12_2PATHWAY
0.00000 0.00000 0.02222TIAN_TNF_SIGNALING_VIA_NFKB
0.02420 0.01057 0.06440ZHU_CMV_ALL_UP
0.09337 0.01658 0.00866KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.10120 0.11568 0.11926NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.00243 0.10358 0.02333LEE_LIVER_CANCER_HEPATOBLAST
0.00002 0.00000 0.01422NAGASHIMA_EGF_SIGNALING_UP
0.00000 0.00009 0.00960HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00027 0.00000 0.06686AMIT_EGF_RESPONSE_60_MCF10A
0.19807 0.15311 0.17601CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00001 0.05697 0.04577CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00195 0.00022 0.00077KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.00010 0.00000 0.09755OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.01991 0.06739 0.00642SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00131 0.00000 0.02395LEONARD_HYPOXIA
0.00000 0.00000 0.02218NCI_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.00017 0.05041 0.00903CROONQUIST_STROMAL_STIMULATION_UP
0.19008 0.04846 0.06757BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.00031 0.03870 0.03077HALMOS_CEBPA_TARGETS_UP
0.15257 0.14952 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.00091 0.00458 0.07135SAGIV_CD24_TARGETS_DN
0.00881 0.01380 0.01757HORIUCHI_WTAP_TARGETS_UP
0.08542 0.10649 0.00580CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00003 0.00009 0.03906HARRIS_HYPOXIA
0.18259 0.00355 0.05936NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00222 0.12957 0.08872DER_IFN_BETA_RESPONSE_UP
0.00448 0.00012 0.00766DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.13279 0.18617 0.00734TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.00000 0.01278 0.00000BASSO_CD40_SIGNALING_UP
0.04261 0.13657 0.02943MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.16807 0.05618 0.00065NCI_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.01502 0.01784 0.04723MARZEC_IL2_SIGNALING_UP
0.00002 0.00000 0.00351NAGASHIMA_NRG1_SIGNALING_UP
0.02994 0.00002 0.00038SOUCEK_MYC_TARGETS
0.06809 0.01992 0.08988TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.03840 0.00100 0.13115ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00002 0.00001 0.00131MAHADEVAN_RESPONSE_TO_MP470_UP
0.00002 0.00002 0.18558FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.00028 0.00132 0.05938BILD_HRAS_ONCOGENIC_SIGNATURE
0.00085 0.00008 0.06350DAUER_STAT3_TARGETS_UP
0.00005 0.00002 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.15088 0.13629 0.00030NETPATH_IL_3_PATHWAY_UP
0.13841 0.01697 0.00719BIOCARTA_CTL_PATHWAY
0.00027 0.01576 0.00000KEGG_LEISHMANIA_INFECTION
0.03716 0.01969 0.00150NETPATH_IL_6_PATHWAY_UP
0.16212 0.06859 0.18281CHO_NR4A1_TARGETS
0.13286 0.16748 0.05856LEE_LIVER_CANCER_ACOX1_UP
0.01027 0.11710 0.07674WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.02293 0.03293 0.01391WU_HBX_TARGETS_1_UP
0.00000 0.00000 0.03578REACTOME_PEPTIDE_CHAIN_ELONGATION
0.11486 0.02345 0.12473BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.00228 0.00000 0.05324DAZARD_UV_RESPONSE_CLUSTER_G2
0.00550 0.00000 0.02231CHEN_HOXA5_TARGETS_9HR_UP
0.00017 0.00040 0.00000MCLACHLAN_DENTAL_CARIES_DN
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00002 0.00677 0.00022GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00000 0.00000 0.00059ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.06632 0.03379 0.00521PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.06119 0.11599 0.00029ZHU_CMV_8_HR_UP
0.00000 0.00000 0.00008SANA_TNF_SIGNALING_UP
0.00030 0.02042 0.02390BIOCARTA_INFLAM_PATHWAY
0.00002 0.00621 0.03587SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.09494 0.00313 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00005 0.01031 0.03586ONDER_CDH1_TARGETS_2_DN
0.00011 0.00008 0.02652HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.06875 0.05209 0.09153SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.01005 0.04896 0.17909SENESE_HDAC3_TARGETS_UP
0.03885 0.12696 0.00209KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.01678 0.01719 0.05665KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.02749 0.00000 0.10221UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00558 0.00823 0.09161XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.02115 0.12825 0.00128BIOCARTA_GRANULOCYTES_PATHWAY
0.00146 0.05412 0.07602XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.14412 0.00874 0.13805BIOCARTA_TOLL_PATHWAY
0.00000 0.00000 0.02849REACTOME_FORMATION_OF_A_POOL_OF_FREE_40S_SUBUNITS
0.00000 0.00000 0.00033GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00011 0.00000 0.10357OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00002 0.00076 0.05374ZUCCHI_METASTASIS_DN
0.00131 0.10547 0.03067BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.00044 0.00000 0.12936PRAMOONJAGO_SOX4_TARGETS_UP
0.06556 0.00000 0.01248PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN